“www.LifeSciences.2023” at Genesis 2022 Featured Image

“www.LifeSciences.2023” at Genesis 2022

07 Dec 22

Who will be the stakeholders shaping and disrupting the sector in 2023 and beyond?
What – technologies, in R&D, drug delivery or related field will provide the best solutions for patients?
When will we see the impacts of the above take effect?

Facilitated by
Paul Branthwaite | Client Liaison | tranScrip

Laura Lane | VP – Venture Sciences (Europe) | Eli Lilly
David Roblin | CEO | Relation Therapeutics
Judit Molnar | Senior Partner, Early Development | tranScrip
Rowan Gardner | Co-Founder |PrecisionLife

Contact our team of experts

We have teams of life science and R&D experts to help achieve your goals and seize opportunities. Whatever your project requires, we have the people to meet your needs.